Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Howden

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Hepato-Gastroenterology|February 1, 1992
Potent versus mild acid suppression in peptic ulcer diseaseC W Howden
Alimentary Pharmacology & Therapeutics|July 19, 2012
Commentary: something new to consider in the treatment of Helicobacter pylori infection?C W Howden
The American Journal of Gastroenterology|April 1, 1997
Optimizing the pharmacology of acid control in acid-related disordersC W Howden
Alimentary Pharmacology & Therapeutics|November 8, 2012
Commentary: PPIs and risk of serious infection in decompensated cirrhosisC W Howden
Alimentary Pharmacology & Therapeutics|April 1, 1988
Review: interactions between H2-antagonists and non-steroidal anti-inflammatory drugsC W Howden
BMJ (Clinical Research Ed.)|November 26, 1988
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefitC W Howden
Alimentary Pharmacology & Therapeutics|November 24, 2005
Review article: immediate-release proton-pump inhibitor therapy--potential advantagesC W Howden
Journal of Clinical Gastroenterology|September 19, 2000
Treatment of Helicobacter pylori infection: is less more?C W Howden
Clinical Pharmacokinetics|January 1, 1991
Clinical pharmacology of omeprazoleC W Howden
Alimentary Pharmacology & Therapeutics|November 8, 2012
Commentary: The link between community-acquired pneumonia and PPI useC W Howden
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Hepato-Gastroenterology|February 1, 1992
Potent versus mild acid suppression in peptic ulcer diseaseC W Howden
Alimentary Pharmacology & Therapeutics|July 19, 2012
Commentary: something new to consider in the treatment of Helicobacter pylori infection?C W Howden
The American Journal of Gastroenterology|April 1, 1997
Optimizing the pharmacology of acid control in acid-related disordersC W Howden
Alimentary Pharmacology & Therapeutics|November 8, 2012
Commentary: PPIs and risk of serious infection in decompensated cirrhosisC W Howden
Alimentary Pharmacology & Therapeutics|April 1, 1988
Review: interactions between H2-antagonists and non-steroidal anti-inflammatory drugsC W Howden
BMJ (Clinical Research Ed.)|November 26, 1988
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefitC W Howden
Alimentary Pharmacology & Therapeutics|November 24, 2005
Review article: immediate-release proton-pump inhibitor therapy--potential advantagesC W Howden
Journal of Clinical Gastroenterology|September 19, 2000
Treatment of Helicobacter pylori infection: is less more?C W Howden
Clinical Pharmacokinetics|January 1, 1991
Clinical pharmacology of omeprazoleC W Howden
Alimentary Pharmacology & Therapeutics|November 8, 2012
Commentary: The link between community-acquired pneumonia and PPI useC W Howden
Pageof 15